SEC Form 4 · accession 0001437749-15-012615
Imunon, Inc. · IMNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael H Tardugno
Officer — CEO · Director
Period of report
Jun 19, 2015
Accepted (ET)
Jun 19, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000749647
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Celsion Corporation Common StockF1,F2 | $2.39 | Jun 19, 2015 | A | 65,000 | A | Jun 19, 2015 | Jun 19, 2025 | Celsion Corporation Common Stock | 65,000 | 648,885 | D |
Explanation of responses
- F1Represents the closing price of Celsion Corporation Common Stock on the date of grant.
- F2The option vests in thirds on June 19, 2015, June 19, 2016 and June 19, 2017.